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Dear Editor, 
 
Lutein is a nutritionally beneficial organic tetraterpenoid pigment; its molecular formula 
and weight are C40H56O2 and 568.87144 g/mol, respectively. It is responsible for the yellow 
color of fruits and vegetables and is found in high levels in parsley, spinach, kale, egg yolk, 
and lutein-fortified foods (Shegokar and Mitri, 2012).  
Lutein has a wide range of beneficial health effects including antioxidant, anti-
inflammatory, antiatherogenic, antihypertensive, antidiabetic, antiulcer, and anticancer effects 
(Miyazawa et al., 2013; Johnson, 2014; Erdman et al., 2015; Manayi et al., 2015). Further-
more, it is used to prevent eye diseases including age-related macular degeneration (AMD), 
cataract, and retinitis pigmentosa (Koushan et al., 2013; Sulich et al., 2015). 
The commercial value of lutein is growing with the customary age-related macular degen-
eration applications. The lutein market is segmented into pharmaceutical, nutraceutical, food, 
pet foods, cosmetics, and animal and fish feed. Lutein shows a range of biological activities 
and health benefits in animals; therefore, herein, we have reviewed the most recent studies on 
lutein and its biological and pharmacological activities (Table 1). 
 
Table 1: Recent studies on lutein and its biological and pharmacological activities 
Key findings Reference 
Interestingly, the combination of lutein with vitamin C which is responsible 
to improve the total antioxidant defense system properties in Sprague-
Dawley (SD) rats is found by Song et al. (2015) 
Song et al., 2015 
The intestinal absorption of both micellar and dietary lutein has been en-
hanced by phosphatidylcholine content. This implies that lutein deficiency 
in aged rats can be improved by phosphatidylcholine. On the other hand 
lutein bioavailability also enriched in lutein deficiency rats by phosphatidyl-
choline which is either in free or bound form with food matrices. 
 
Sheshappa et al., 2015 
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Table 1 (cont.): Recent studies on lutein and its biological and pharmacological activities 
Key findings Reference 
Higher intakes of lutein-containing foods, including green leafy vegetables, 
were associated with higher levels of physical activity. Increasing the con-
sumption of lutein-rich foods may have a positive effect on levels of physi-
cal activity. 
Crichton et al., 2015 
In order to identify the role of lutein in human brain, study of relationship 
between lutein and metabolic pathways is an important and useful criterion. 
Fundamental understanding of the relationships between lutein correlation 
with lipid pathway metabolites, energy pathway metabolites, brain osmo-
lytes, amino acid neurotransmitters, and the antioxidant homocarnosine 
plays an important role for further analysis specifically in brain develop-
ment. 
Lieblein-Boff et al., 
2015 
Lutein treatment exerted potent antioxidant and anti-inflammatory effects 
and offered significant cytoprotection against alcohol-induced liver injury. Du et al., 2015 
Lutein protects against skeletal ischemia/reperfusion injury by downregu- 
lating oxidative stress and inflammatory mechanisms. Cheng et al., 2015 
Lutein has positive effects on non-alcoholic fatty liver disease via the modu-
lation of hepatic lipid accumulation and insulin resistance. Qiu et al., 2015 
Lutein has potential beneficial effects in diabetes-induced testicular dam-
age, probably through its antioxidant and anti-inflammatory properties. Fatani et al., 2015 
Lutein attenuates neuroinflammation in lipopolysaccharide-activated BV-2 
microglia, partly through the inhibition of p38-, c-Jun N-terminal kinase 
(JNK)-, and Akt-stimulated NF-ĸB activation and promotion of extracellular 
signal-regulated kinase-induced NF-E2-related factor 2 activation, suggest-
ing that it has great potential as a nutritional preventive strategy in inflam-
mation-related neurodegenerative disorders. 
Wu et al., 2015 
Long-term lutein supplementation could increase serum lutein concentra-
tion, macular pigment optical density (MPOD), and visual sensitivity in early 
age-related macular degeneration (AMD) patients. The advisable long-term 
lutein dosage for early AMD treatment is 10 mg daily. 
Huang et al., 2015 
Lutein has antioxidant properties and can thus prevent hepatotoxicity. This 
finding also suggests that dietary lutein may be a potential treatment for  
liver diseases, especially arsenicosis. 
Li et al., 2015 
New evidence supports the antiatherogenic properties of lutein and the 
mechanism of action underlying its atherosclerosis-preventive effect in-
volves improvements in oxidative stress and lipid metabolism. 
Han et al., 2015 
Lutein modulates the expression of growth- and survival-associated genes 
in prostate cancer cells. Rafi et al., 2015 
In the case of lutein supplementation it inhibits the systemic activation of 
the complement system. This finding is the strong evidence for the reported 
beneficial effects about the management of AMD. 
Tian et al., 2015 
It is important to mention here that lutein/zeaxanthin-based dye solutions 
accomplished a safe profile for in vitro and in vivo studies. This result has 
been shown as a better choice for staining intraocular structures. 
Casaroli-Marano et al., 
2015 
Even though lutein supplementation is useful for enhancing visual acuity 
based on improving MPOD done by Wang et al. (2014), but still more re-
search work is still needed to give appropriate conclusive evidence. In the 
case of dosage per day analysis it is found that milder dose is much effec-
tive compared to higher dose. 
Wang et al., 2014 
The intestinal absorption of lutein and zeaxanthin may be improved by 
physiological and pharmacological interventions affecting high-density lipo-
protein (HDL) metabolism. 
Niesor et al., 2014 
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Table 1 (cont.): Recent studies on lutein and its biological and pharmacological activities 
Key findings Reference 
Lutein can inhibit platelet-derived growth factor-BB induced migration of ret-
inal pigment epithelium cells through the inhibition of both cytoplasmic and 
mitochondrial Akt activation. 
Su et al., 2014 
It is well known that lutein has antioxidant properties. That administration of 
lutein affords strong neuroprotective effect against transient cerebral ische-
mic injury is the strong evidence for its exclusive antioxidant properties. 
Sun et al., 2014 
Lutein-fortified formula was safe and well-tolerated and supported the  
physical growth of evaluated infants. Kon et al., 2014 
Silk lutein extract enhanced both innate and adaptive immune functions, 
and may prove to be an effective supplement to strengthen immunity. Promphet et al., 2014 
Lutein and zeaxanthin alone or in association with brilliant blue showed a 
good safety profile in this experimental model. Furlani et al., 2014 
Lutein might scavenge reactive species and induce the expression of 
genes related to a better antioxidant response, thereby improving oxygen 
transport. The improvement in the redox state of cells through lutein treat-
ment could be related to the antigenotoxic and antioxidant effects of lutein. 
Serpeloni et al., 2014 
It is important to mention here that the voluntary running of rats is the very 
good choice to enhance effective utilization of lipids. Interestingly the lutein 
level in the blood of rats significantly decreased with exercise. Therefore 
voluntary running and lutein fortified milk both are the combined source for 
utilization of lipids. 
Matsumoto et al., 2014 
Lutein is a promising content in medical field especially neural development 
in preterm infants. Regarding the preferential accumulation and mainte-
nance of lutein have been studied and reported by Vishwanathan et al. 
(2014). This study is a pathway for further investigations regarding preterm 
infants. 
Vishwanathan et al., 
2014 
Higher lutein, zeaxanthin, and vitamin C concentrations in plasma are in-
corporated with prolonged leukocyte telomere length in common elderly 
humans and indicate a defensive role of these vitamins in telomere mainte-
nance. 
Sen et al., 2014 
Nowadays Alzheimer's disease (AD) mortality in adults becomes global 
concern. Lycopene, lutein and zeaxanthin are the important factors in se-
rum which are responsible to induce AD mortality in adults. From the re-
sults it is evident that above mentioned three factors should be high in se-
rum level. Therefore it is concluded that from the findings high intake of ly-
copene, lutein and zeaxanthin enriched foods only can meet out the re-
quirements to reduce the risk of AD mortality. 
Min and Min, 2014 
Nowadays age-related cataract (ARC) has paramount of importance 
among aged people. Lutein and zeaxanthin contents are suitable candi-
dates to reduce the risk of age-related cataract (ARC). Hence the proper in-
take of lutein and zeaxanthin plays key source for ARC prevention espe-
cially for nuclear cataract. 
Ma et al., 2014 
The novel powerful agents named lutein and zeaxanthin which are having 
great importance in AMD therapy successfully extracted from Fructus lycii. 
In vitro and in vivo studies clearly explains beneficial role of active compo-
nents lutein and zeaxanthin in AMD therapy. 
Xu et al., 2013a 
Lutein is a promising material extensively used for body weight and neuro-
behavioral alterations, attenuated oxidative stress, and improved the activi-
ty of the mitochondrial enzymes complex in rat brain. The performance of 
lutein against the Huntington's disease is also studied and reported. 
Binawade et al., 2013 
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Table 1 (cont.): Recent studies on lutein and its biological and pharmacological activities 
Key findings Reference 
Intestinal damage during conventional chemotherapy is a major challenge 
in rats for researches. Interestingly, lutein pre-treatment is a best choice to 
prevent intestinal damage. Form this study the methotrexate-induced apop-
tosis of IEC-6 cells originating from rat jejunum crypt was studied and ex-
plained in proper way. 
Chang et al., 2013 
In order to control the inflammatory pathway of the innate immune system 
lutein is an appropriate choice for researches. It possesses simple method 
to control the circulating levels of complement factors includes C5a and 
C3d. 
Tian et al., 2013 
Constant light conditions during the perinatal period may induce some  
neuronal abnormalities in both offspring and mother that may be partially 
ameliorated by the antioxidant effects of dietary lutein.  
Yajima et al., 2013 
Lutein has significant antihypertensive and antioxidant effects against  
hypertension induced by N(G)-nitro-L-arginine methyl ester hydrochloride  
in rats.  
Sung et al., 2013 
Usage of lutein has been extensively applied in medical field especially for 
preterm infants due to its excellent biological antioxidant property. Many re-
searches are going on to understand the excellent biological activity of lute-
in for preterm infants. But this research area is still required novel and in-
novative pathways and solutions in developing new drugs for preterm in-
fants. 
Costa et al., 2013 
Lutein supplementation reduced the levels of biomarkers of cardiovascular 
diseases by decreasing the lipid peroxidation and inflammatory response 
by increasing plasma lutein concentration and antioxidant capacity. 
Wang et al., 2013 
Daily supplementation with 20 mg of lutein increases macular pigment opti-
cal density. Lutein may improve the ability to drive at night and to perform 
other spatial discrimination tasks under low illumination. 
Yao et al., 2013 
Atherosclerosis is a well-known vascular disease. It is reported that high lu-
tein level in serum can regulate serum lipids and cytokines which are re-
sponsible for early atherosclerosis. From this study it is evident that lutein 
level in serum plays a key role to control vascular diseases. 
Xu et al., 2013b 
Lutein has protective effects against B(a)P-induced oxidative stress, possi-
bly by combating oxidative stress by its free radical scavenging activity.  
Vijayapadma et al., 
2014 
Fundamental understanding of lutein exhibits rich and fascinating proper-
ties of lutein in biomedical field. It is a potent neuroprotective agent that can 
salvage photoreceptors in rats. From the observations it is concluded that 
lutein is a milestone of drug designing process for various diseases. 
Woo et al., 2013 
The antiulcer activity of lutein may be attributable to the inhibition of oxida-
tive stress produced by alcohol. These findings suggest the potential thera-
peutic use of lutein as an effective antiulcer agent. 
Sindhu et al., 2012 
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